A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug ...

Adding dostarlimab to platinum-based chemotherapy and niraparib improved PFS in patients with advanced ovarian cancer.

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, chemotherapy or radiation, the study found.

A study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that combining the immunotherapy drug dostarlimab with ...

This phase 2 study builds on previous landmark research, in which colorectal cancer patients receiving the immunotherapy drug dostarlimab experienced complete tumor remission. In recognition of ...

Dostarlimab, a programmed death receptor-1 (PD-1)-blocking antibody, completely eradicated rectal cancer tumors without the need for surgery, radiation treatment or chemotherapy.

“For as long as cancer treatment has existed ... It’s all thanks to dostarlimab, a drug initially discovered by AnaptysBio, and that is being manufactured and brought to market by ...

For many, the word cancer brings images of hospitals, surgeries, and long, exhausting treatments. But a new drug therapy—dostarlimab—has quietly created a ripple of hope in the cancer world.

A new study in the New England Journal of Medicine suggests that some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab.

For a limited group of cancer patients who have solid ... Diaz Jr. and Dr. Andrea Cercek, decided to give dostarlimab, an immunotherapy drug, on its own. The result was stunning, and could bring ...